Autopsy report · NCT07388394
Polypharmacy on Healthy Aging in People Living With HIV Over the Age of 75
Cause of deathRegulatory or ethics
“The inclusions have been suspended pending approval of an amendment to the protocol”
Life of this trial
- Suspended: paused, and may or may not restart.
- 136 participants planned (an estimate, not an actual count).
Vital statistics
- Status
- Suspended
- Phase
- Na
- Sponsor
- Centre Hospitalier Universitaire de Nice
- Sponsor type
- University, hospital or other
- Conditions
- Virus-HIV
- Interventions
- interview with advanced practice nurse
- Participants
- 136 (planned, not actual)
- Sites
- 1
- Countries
- France
Trials that died the same way
- Glofitamab With Obinutuzumab Pre-treatment for the Treatment of Central Nervous System Lymphoma
“Pending Amendment Approval” - EXOme Rare Cancers in Children (EXOCARE)
“Inclusions stopped due to lack of inclusions” - Bortezomib in Combination With Ibrutinib in Ibrutinib Relapsed Mantle Cell Lymphoma
“Enrollment and/or interactions/interventions temporarily paused due to COVID-19 and expected to resume in the future. This is not a suspension of IRB approval.” - Internet Cognitive Behavioral Therapy for Insomnia to Prevent Cardiovascular Disease
“Intervention services were suspended and then unavailable.” - Etude Tomos- Apport de la Tomosynthèse Dans le Bilan d'Extension locorégional préthérapeutique d'Une Tumeur du Sein : Recherche de multicentricité Tomos Study- Contribution of Tomosynthesis In Locoregional Pretherapeutic Staging of a Breast Tumor: Multicentricity Search
“No more inclusions since august 2013”
Look deeper
- The official registry record (the source of truth)
- Record history: every change the sponsor made
- Open it in the database
Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.